Bookmark and Share

Compound Summary for: CID 11556711

carfilzomib

Also known as: Kyprolis; 868540-17-4; PR-171; Carfilzomib (PR-171); UNII-72X6E3J5AR; CHEBI:65347; NCGC00249613-01; DSSTox_CID_28616
Molecular Formula: C40H57N5O7   Molecular Weight: 719.90988   InChIKey: BLMPQMFVWMYDKT-NZTKNTHTSA-N
Carfilzomib is an injectable antineoplastic agent (IV only). Chemically, it is a modified tetrapeptidyl epoxide and an analog of epoxomicin. It is also a selective proteasome inhibitor. FDA approved on July 20, 2012.    From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show first sub-section only
Use and Manufacturing
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _